Anzeige
Mehr »
Login
Dienstag, 01.10.2024 Börsentäglich über 12.000 News von 692 internationalen Medien
Goldpreis steigt 2024 um 30 %, aber diese Aktie legt über 333 % zu – Hier ist der Grund
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
476 Leser
Artikel bewerten:
(2)

FlowForma Selected As Approved Vendor for Workflow Automation on NHS Shared Tenancy 'N365'

DUBLIN, June 9, 2022 /PRNewswire/ -- FlowForma, the leading provider of Process Automation tools for Microsoft Office 365, today announced it has been selected by NHS Digital as an approved vendor for the provision of its award-winning FlowForma Process Automation tool for NHS trusts, across the United Kingdom.

Olivia Bushe, Chief Executive Officer, FlowForma

As a direct result of the COVID-19 pandemic, the NHS prioritised implementing a shared tenancy, 'N365', to increase collaboration and improve productivity among staff. With over one million users to date, procuring solutions to further drive efficiency and create a culture of continuous improvement became a priority for NHS staff.

The NHS London Procurement Partnership (LPP) provides a portal to its members to support the procurement process and facilitate contract management with suppliers nationwide. FlowForma has been recognised as a proven vendor to aid the digital transformation of NHS trusts across the United Kingdom.

The 3-in-1 FlowForma Process Automation tool combining forms, workflow, and document generation is a proven solution to replace paper, excel spreadsheets, and email-based processes across healthcare institutions. The 100% no-code tool features rapid prototyping capabilities that empower process owners to deploy digital processes at speed and scale across hospitals and other public bodies, ultimately delivering better patient/customer experiences.

Blackpool Teaching Hospitals NHS Foundation Trust is one such institution who are reaping the rewards from digitising. Mark Greenwood, Senior Developer, Blackpool Teaching Hospitals NHS Foundation Trust, and his team have automated and streamlined more than 40 processes with further areas for transformation outlined.

"We had brought some processes online using other tools, but the speed of development and the opportunity to involve process owners in creating their own forms and workflows using FlowForma Process Automation is a game-changer. A process automation solution that can be procured easily for NHS trusts like ours is key to assist a wider transformation across the entire NHS ecosystem. We hope we can act as a successful business case for others to follow in the future," said Mark Greenwood, Senior Developer, Blackpool Teaching Hospitals NHS Foundation Trust.

"For us, it was about leveraging the national tenant to gain further efficiencies and adopting an internet-first approach to cyber security. FlowForma was part of our core PASA (Provisioning and System Access) solutions and the ability to create workflows quickly with governance from IT, without being reliant on them, is critical as we seek to further automate in other areas," said Shaun Bucknill, Head of ICT & Acting Deputy CIO, Blackpool Teaching Hospitals NHS Foundation Trust.

Olivia Bushe, CEO of, FlowForma added, "We are delighted to be selected as a vendor for the NHS's 'N365' shared tenancy. The FlowForma Process Automation tool will provide NHS bodies with a proven process automation solution to deliver rapid results throughout healthcare institutions.

"We are excited to continue working with NHS trusts and other institutions having recently also been selected by the NHS London Procurement Partnership as a trusted solutions provider to digitise processes and ultimately improve patient care as a result."

To accelerate process automation, FlowForma has recently launched a set of fully editable common process accelerator templates for this sector, helping organisations to digitise their business processes with speed and flexibility whilst encouraging adoption across all departments. Users can benefit from process templates such as:

  • Monthly Housekeeping Inspection
  • Hospital to Hospital Transfer Referral Form
  • Incident Report
  • IT Request
  • Medication Incident Report
  • Theatre Notes
  • Transfer Request
  • Waiting List Card
  • Consent for Release of Information

Users can benefit from our process accelerators and more by taking a free 14-day trial of the FlowForma Process Automation tool.

Supporting Resources:
  • To learn more about how FlowForma is empowering the healthcare sector visit:
    www.flowforma.com/helping-healthcare
  • To find out how the FlowForma Process Automation tool works visit:
    www.flowforma.com/how-it-works
  • To download a free 14-day trial of FlowForma Process Automation visit:
    www.flowforma.com/start-your-flowforma-trial
  • To learn more about FlowForma Process Automation, book a demo with one of our experts:
    www.flowforma.com/book-a-demo
  • To find out how FlowForma Process Automation compares against its peer's visit:
    www.g2crowd.com/products/flowforma-process-automation/reviews
About FlowForma

FlowForma is the leading provider of enterprise-class, no-code business process management, and automation tools that empower business people to rapidly digitise a wide range of processes.

The company empowers businesspeople in construction, engineering, healthcare, financial services, and more, to digitise complex business processes in-house, without writing any software code.

Customers are live with digital processes, empowered and self-sufficient within 4 weeks of onboarding. Users rapidly reap ROI, resilience, and innovation. FlowForma Process Automation is making waves in the automation space with its process accelerators, external stakeholder engagement, and offline capability.

FlowForma is a Microsoft Gold Partner, with over 200,000 global users. The company is headquartered in Ireland with offices in Boston and London and is motivated by its values to innovate, evolve, and achieve with employees, customers, and partners.

For further information or a 14-day free trial, visit www.flowforma.com.

Photo - https://mma.prnewswire.com/media/1835835/FlowForma_CEO.jpg
Logo - https://mma.prnewswire.com/media/715823/FlowForma_Logo.jpg

FlowForma Logo

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.